Zdrowie i gospodarka · 04/10/2005

FDA Publishes Guidance for AFP-L3% Immunological Test Systems

The FDA has released a guidance document outlining the requirements for AFP-L3% immunological test systems to comply with special controls for class II devices, following the recent classification of these systems into class II under a final rule published in the Federal Register.